ITRACONAZOLE Side Effects

7014171-4 | Enterococcus Test Positive, Hepatic Steatosis
on Sep 15, 2010 Male patient from CHINA , 61 years of age, was diagnosed with onychomycosis and was treated with Itraconazole (View Usage). Patient experienced the following unwanted or unexpected effects: enterococcus test positive, hepatic steatosis. Itraconazole dosage: . During the same period patient was treated with MUPIROCIN (View Mupirocin Review and Mupirocin Label ), ANTIBIOTIC (View Antibiotic Review and Antibiotic Label ). Patient was hospitalized.

7006649-4 | Dyspnoea Exertional, Incorrect Dose Administered, Weight Increased
Patient was taking Itraconazole (View Usage). Patient had the following side effects: dyspnoea exertional, incorrect dose administered, weight increased on Sep 21, 2010 from UNITED STATES Additional patient health information: Male patient , 70 years of age, weighting 252.2 lb, was diagnosed with blastomycosis and. Itraconazole dosage: 200mg Bid Po.

6979246-4 | Cardiac Failure, Electrolyte Imbalance, Hypertension, Hypoproteinaemia
Adverse event was reported on Sep 06, 2010 by a Male patient taking Itraconazole (View Usage) (Dosage: ) was diagnosed with fungal infection (What is fungal infection?) and. Location: CHINA , 78 years of age, After Itraconazole was administered, patient had the following side effects: cardiac failure, electrolyte imbalance, hypertension, hypoproteinaemia. During the same period patient was treated with AVELOX (View Avelox Review and Avelox Label ), CARBENIN (View Carbenin Review and Carbenin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).

6969528-4 | Abdominal Pain Upper, Insomnia, Pruritus, Rash, Scratch
on Sep 07, 2010 Female patient from UNITED STATES , 57 years of age, weighting 168.0 lb, was diagnosed with onychomycosis and was treated with Itraconazole (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, insomnia, pruritus, rash (What is rash?), scratch. Itraconazole dosage: 2 Each Morning.


6962504-7 | Hypercalcaemia, Renal Failure Acute, Retinoic Acid Syndrome
on Sep 01, 2010 Male patient from SPAIN , 38 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Itraconazole (View Usage). Patient had the following side effects: hypercalcaemia, renal failure acute, retinoic acid syndrome. Itraconazole dosage: . During the same period patient was treated with TRETINOIN (View Tretinoin Review and Tretinoin Label ), COTRIM (View Cotrim Review and Cotrim Label ), ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ), IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ).

6962503-5 | Hypercalcaemia, Renal Failure Acute, Retinoic Acid Syndrome
Patient was taking Itraconazole (View Usage). After Itraconazole was administered, patient had the following side effects: hypercalcaemia, renal failure acute, retinoic acid syndrome on Aug 26, 2010 from SPAIN Additional patient health information: Male patient , 38 years of age, was diagnosed with acute promyelocytic leukaemia and. Itraconazole dosage: . During the same period patient was treated with TRETINOIN (View Tretinoin Review and Tretinoin Label ), COTRIM (View Cotrim Review and Cotrim Label ), ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ), IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ).

6945671-0 | Neuropathy Peripheral, Neutropenia, Sensorimotor Disorder, Thrombocytopenia
Adverse event was reported on Aug 18, 2010 by a Male patient taking Itraconazole (View Usage) (Dosage: 200 Mg/day) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: JAPAN , 61 years of age, Patient experienced the following unwanted or unexpected effects: neuropathy peripheral, neutropenia, sensorimotor disorder, thrombocytopenia. During the same period patient was treated with BORTEZOMIB (1.3 Mg/m2, On Days 1, 2, 8, 11) (View Bortezomib Review and Bortezomib Label ), DEXAMETHASONE (20 Mg, (on Days 1, 2, 4, 5, 8, 9, 11, And 12)) (View Dexamethasone Review and Dexamethasone Label ).

6945670-9 | Neuropathy Peripheral, Neutropenia, Sensorimotor Disorder, Thrombocytopenia
on Aug 18, 2010 Male patient from JAPAN , 52 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Itraconazole (View Usage). Patient had the following side effects: neuropathy peripheral, neutropenia, sensorimotor disorder, thrombocytopenia. Itraconazole dosage: 200 Mg/day. During the same period patient was treated with BORTEZOMIB (1.3 Mg/m2 On Days 1, 4, 8 And 11) (View Bortezomib Review and Bortezomib Label ), DEXAMETHASONE (20 Mg On Days 1, 2, 4, 5, 8, 9, 11, 12) (View Dexamethasone Review and Dexamethasone Label ).

6945667-9 | Neuropathy Peripheral, Sensorimotor Disorder, Thrombocytopenia
on Aug 18, 2010 Male patient from JAPAN , 56 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Itraconazole (View Usage). After Itraconazole was administered, patient had the following side effects: neuropathy peripheral, sensorimotor disorder, thrombocytopenia. Itraconazole dosage: 200 Mg/day. During the same period patient was treated with BORTEZOMIB (1.3 Mg/m2 On Days 1, 4, 8 And 11) (View Bortezomib Review and Bortezomib Label ), DEXAMETHASONE (20 Mg On Day 1, 2, 4, 5, 8, 9, 11, 12) (View Dexamethasone Review and Dexamethasone Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ).

6944410-7 | Hypercalcaemia, Renal Failure Acute
Patient was taking Itraconazole (View Usage). Patient experienced the following unwanted or unexpected effects: hypercalcaemia, renal failure acute on Aug 17, 2010 from SPAIN Additional patient health information: Male patient , 38 years of age, was diagnosed with acute promyelocytic leukaemia and. Itraconazole dosage: . During the same period patient was treated with ATRA (ALL TRANS RETINOIC ACID) (View Atra (all Trans Retinoic Acid) Review and Atra (all Trans Retinoic Acid) Label ), COTRIM (800/160 Mg) (View Cotrim Review and Cotrim Label ), ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ), IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ).

6942775-3 | Hypercalcaemia, Renal Failure Acute, Retinoic Acid Syndrome
Adverse event was reported on Aug 17, 2010 by a Male patient taking Itraconazole (View Usage) (Dosage: ) was diagnosed with acute promyelocytic leukaemia and. Location: SPAIN , 38 years of age, Patient had the following side effects: hypercalcaemia, renal failure acute, retinoic acid syndrome. During the same period patient was treated with TRETINOIN (View Tretinoin Review and Tretinoin Label ), COTRIM (View Cotrim Review and Cotrim Label ), ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ), IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ).

6942012-X | Renal Failure, Respiratory Failure
on Aug 20, 2010 Male patient from VIET NAM , 30 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Itraconazole (View Usage). After Itraconazole was administered, patient had the following side effects: renal failure, respiratory failure. Itraconazole dosage: . During the same period patient was treated with CEFOPERAZON SULBACTAM (View Cefoperazon-sulbactam Review and Cefoperazon-sulbactam Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), COTRIM (View Cotrim Review and Cotrim Label ), IMIPENEM AND CILASTATIN SODIUM (View Imipenem And Cilastatin Sodium Review and Imipenem And Cilastatin Sodium Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ).

6919741-7 | Cardiac Failure Congestive, Headache, Palpitations, Pulmonary Oedema
on Aug 10, 2010 Female patient from UNITED STATES , 72 years of age, weighting 180.8 lb, was diagnosed with bronchopulmonary aspergillosis allergic and was treated with Itraconazole (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, headache (What is headache?), palpitations, pulmonary oedema. Itraconazole dosage: 400mg Twice Daily Oral. During the same period patient was treated with DILTIAZEM (View Diltiazem Review and Diltiazem Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CA W/D (View Ca W/d Review and Ca W/d Label ), CAPTOPRIL (View Captopril Review and Captopril Label ). Patient was hospitalized.

6919642-4 | Grand Mal Convulsion
Patient was taking Itraconazole (View Usage). Patient had the following side effects: grand mal convulsion on Aug 03, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 16 years of age, was diagnosed with bronchopulmonary aspergillosis allergic, cystic fibrosis and. Itraconazole dosage: 200 Mg, Unk. During the same period patient was treated with CALCICHEW D3 (Q) (View Calcichew D3 Review and Calcichew D3 Label ), COLOMYCIN (2 Miu, Bid) (View Colomycin Review and Colomycin Label ), CREON (Once A Day) (View Creon Review and Creon Label ), DALIVIT (0.6 Ml, Qd) (View Dalivit Review and Dalivit Label ), PREDNISOLONE (10 Mg, Qd) (View Prednisolone Review and Prednisolone Label ), PULMOZYME (2.5 Ml, Qd) (View Pulmozyme Review and Pulmozyme Label ), ALBUTEROL SULFATE AUTOHALER (5 Mg, Bid) (View Albuterol Sulfate Autohaler Review and Albuterol Sulfate Autohaler Label ).

6916885-0 | Fungal Infection, Neutropenia, Organising Pneumonia
Adverse event was reported on Aug 03, 2010 by a Male patient taking Itraconazole (View Usage) (Dosage: ) was diagnosed with prophylaxis, antifungal prophylaxis, acute myeloid leukaemia and. Location: ITALY , 49 years of age, After Itraconazole was administered, patient had the following side effects: fungal infection (What is fungal infection?), neutropenia, organising pneumonia. During the same period patient was treated with POSACONAZOLE (View Posaconazole Review and Posaconazole Label ), LIPOSOMAL AMPHOTERICIN B (View Liposomal Amphotericin B Review and Liposomal Amphotericin B Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ).

6911340-6 | Purpura
on Jul 30, 2010 Male patient from JAPAN , 75 years of age, was diagnosed with onychomycosis and was treated with Itraconazole (View Usage). Patient experienced the following unwanted or unexpected effects: purpura. Itraconazole dosage: . During the same period patient was treated with WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6910122-9 | Disease Progression
on Jul 27, 2010 Female patient from UNITED STATES , 19 years of age, was treated with Itraconazole (View Usage). Patient had the following side effects: disease progression. Itraconazole dosage: . During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), PIPERACILLIN AND TAZOBACTAM (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ), TRIMETHOPRIM + SULFAMETHOXAZOLE (View Trimethoprim + Sulfamethoxazole Review and Trimethoprim + Sulfamethoxazole Label ), LINEZOLID (View Linezolid Review and Linezolid Label ).

6910105-9 | Bronchopulmonary Aspergillosis, Haemoglobin Decreased, Haemoptysis, Presyncope, Vascular Pseudoaneurysm
Patient was taking Itraconazole (View Usage). After Itraconazole was administered, patient had the following side effects: bronchopulmonary aspergillosis, haemoglobin decreased, haemoptysis, presyncope, vascular pseudoaneurysm on Jul 27, 2010 from UNITED STATES Additional patient health information: Male patient , 82 years of age, . Itraconazole dosage: . During the same period patient was treated with PROTON PUMP INHIBITOR (View Proton Pump Inhibitor Review and Proton Pump Inhibitor Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ). Patient was hospitalized.

6909172-8 | Grand Mal Convulsion
Adverse event was reported on Aug 03, 2010 by a Female patient taking Itraconazole (View Usage) (Dosage: ) was diagnosed with cystic fibrosis, bronchopulmonary aspergillosis allergic and. Location: UNITED KINGDOM , 16 years of age, Patient experienced the following unwanted or unexpected effects: grand mal convulsion. During the same period patient was treated with CALCICHEW D3 (View Calcichew D3 Review and Calcichew D3 Label ), COLISTIN (View Colistin Review and Colistin Label ), CREON (View Creon Review and Creon Label ), DALIVIT (View Dalivit Review and Dalivit Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), PULMOZYME (View Pulmozyme Review and Pulmozyme Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

6909140-6 | Fungal Infection, Organising Pneumonia
on Aug 03, 2010 Male patient from ITALY , 53 years of age, was diagnosed with prophylaxis, acute myeloid leukaemia and was treated with Itraconazole (View Usage). Patient had the following side effects: fungal infection (What is fungal infection?), organising pneumonia. Itraconazole dosage: . During the same period patient was treated with CASPOFUNGIN (View Caspofungin Review and Caspofungin Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ).

6909139-X | Disease Progression, Respiratory Failure
on Aug 03, 2010 Male patient from ITALY , 74 years of age, was diagnosed with prophylaxis and was treated with Itraconazole (View Usage). After Itraconazole was administered, patient had the following side effects: disease progression, respiratory failure. Itraconazole dosage: . During the same period patient was treated with AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6895089-4 | Electrocardiogram St-t Change, Malaise, Nausea, Nodal Rhythm
Patient was taking Itraconazole (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram st-t change, malaise, nausea (What is nausea?), nodal rhythm on Jul 22, 2010 from UNITED STATES Additional patient health information: Male patient , 48 years of age, was diagnosed with coccidioidomycosis and. Itraconazole dosage: . During the same period patient was treated with AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ).

6886951-7 | Disease Progression, Respiratory Failure
Adverse event was reported on Jul 20, 2010 by a Male patient taking Itraconazole (View Usage) (Dosage: ) was diagnosed with prophylaxis and. Location: ITALY , 74 years of age, Patient had the following side effects: disease progression, respiratory failure. During the same period patient was treated with AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6886950-5 | Fungal Infection, Neutropenia, Organising Pneumonia
on Jul 20, 2010 Male patient from ITALY , 49 years of age, was diagnosed with prophylaxis, antifungal prophylaxis, acute myeloid leukaemia and was treated with Itraconazole (View Usage). After Itraconazole was administered, patient had the following side effects: fungal infection (What is fungal infection?), neutropenia, organising pneumonia. Itraconazole dosage: . During the same period patient was treated with POSACONAZOLE (View Posaconazole Review and Posaconazole Label ), LIPOSOMAL AMPHOTERICIN B (View Liposomal Amphotericin B Review and Liposomal Amphotericin B Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ).

6886949-9 | Fungal Infection, Organising Pneumonia
on Jul 20, 2010 Male patient from ITALY , 53 years of age, was diagnosed with prophylaxis, acute myeloid leukaemia and was treated with Itraconazole (View Usage). Patient experienced the following unwanted or unexpected effects: fungal infection (What is fungal infection?), organising pneumonia. Itraconazole dosage: . During the same period patient was treated with CASPOFUNGIN (View Caspofungin Review and Caspofungin Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ).

6878369-8 | Purpura
Patient was taking Itraconazole (View Usage). Patient had the following side effects: purpura on Jul 20, 2010 from JAPAN Additional patient health information: Male patient , 75 years of age, was diagnosed with onychomycosis and. Itraconazole dosage: . During the same period patient was treated with WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6875490-5 | Meningitis
Adverse event was reported on Jul 16, 2010 by a Male patient taking Itraconazole (View Usage) (Dosage: ) . Location: BRAZIL , 27 years of age, After Itraconazole was administered, patient had the following side effects: meningitis (What is meningitis?). During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ). Patient was hospitalized.

6875489-9 | Meningitis
on Jul 16, 2010 Male patient from BRAZIL , 37 years of age, was diagnosed with sporotrichosis and was treated with Itraconazole (View Usage). Patient experienced the following unwanted or unexpected effects: meningitis (What is meningitis?). Itraconazole dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ). Patient was hospitalized.

6875396-1 | Cardiac Failure, Electrolyte Imbalance, Hypertension, Hypoproteinaemia
on Jul 22, 2010 Male patient from CHINA , 78 years of age, was diagnosed with fungal infection (What is fungal infection?) and was treated with Itraconazole (View Usage). Patient had the following side effects: cardiac failure, electrolyte imbalance, hypertension, hypoproteinaemia. Itraconazole dosage: . During the same period patient was treated with AVELOX (View Avelox Review and Avelox Label ), CARBENIN (View Carbenin Review and Carbenin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).

6863034-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatic Enzyme Increased
Patient was taking Itraconazole (View Usage). After Itraconazole was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic enzyme increased on Jul 07, 2010 from UNITED STATES Additional patient health information: Male patient , 25 years of age, . Itraconazole dosage: . During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ).

6860633-X | Disease Progression
Adverse event was reported on Jul 07, 2010 by a Male patient taking Itraconazole (View Usage) (Dosage: ) was diagnosed with chronic graft versus host disease and. Location: GERMANY , 59 years of age, Patient experienced the following unwanted or unexpected effects: disease progression. During the same period patient was treated with PREDNISOLONE (Stopped 8 Weeks Before Admission) (View Prednisolone Review and Prednisolone Label ).

6844772-5 | Abdominal Pain, Lymphadenopathy, Purulent Discharge, Pyrexia
on Jul 06, 2010 Male patient from BRAZIL , child 12 years of age, was diagnosed with paracoccidioides infection and was treated with Itraconazole (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), lymphadenopathy, purulent discharge, pyrexia. Itraconazole dosage: . During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM (8 Mg/kg, Daily) (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), AMPHOTERICIN B (1 Mg/kg, Daily) (View Amphotericin B Review and Amphotericin B Label ). Patient was hospitalized.

6844767-1 | Eosinophilia, Hypersensitivity, Lymphadenopathy, Purulent Discharge, Pyrexia, Rash, Weight Decreased
on Jul 06, 2010 Male patient from BRAZIL , 14 years of age, was diagnosed with paracoccidioides infection and was treated with Itraconazole (View Usage). After Itraconazole was administered, patient had the following side effects: eosinophilia, hypersensitivity, lymphadenopathy, purulent discharge, pyrexia, rash (What is rash?), weight decreased. Itraconazole dosage: 200 Mg, Qd. During the same period patient was treated with SULFADIAZINE (NGX) (4 G, Daily) (View Sulfadiazine (ngx) Review and Sulfadiazine (ngx) Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (8 Mg/kg, Tid) (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ). Patient was hospitalized.

6844436-8 | Neuropathy Peripheral, Thrombocytopenia
Patient was taking Itraconazole (View Usage). Patient experienced the following unwanted or unexpected effects: neuropathy peripheral, thrombocytopenia on Jul 06, 2010 from JAPAN Additional patient health information: Male patient , 56 years of age, was diagnosed with infection prophylaxis, multiple myeloma (What is multiple myeloma?) and. Itraconazole dosage: 21 Day Cycle. During the same period patient was treated with BORTEZOMIB (View Bortezomib Review and Bortezomib Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

6844435-6 | Neuropathy Peripheral, Neutropenia, Thrombocytopenia
Adverse event was reported on Jul 06, 2010 by a Male patient taking Itraconazole (View Usage) (Dosage: ) was diagnosed with infection prophylaxis, multiple myeloma (What is multiple myeloma?) and. Location: JAPAN , 52 years of age, Patient had the following side effects: neuropathy peripheral, neutropenia, thrombocytopenia. During the same period patient was treated with BORTEZOMIB (View Bortezomib Review and Bortezomib Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6844425-3 | Neuropathy Peripheral, Neutropenia, Thrombocytopenia
on Jul 06, 2010 Male patient from JAPAN , 61 years of age, was diagnosed with infection prophylaxis, multiple myeloma (What is multiple myeloma?) and was treated with Itraconazole (View Usage). After Itraconazole was administered, patient had the following side effects: neuropathy peripheral, neutropenia, thrombocytopenia. Itraconazole dosage: . During the same period patient was treated with BORTEZOMIB (On Days 1,4.8 And 11) (View Bortezomib Review and Bortezomib Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6822112-5 | Acute Myocardial Infarction, Cardiac Failure Congestive, Condition Aggravated, Respiratory Failure
on Jul 06, 2010 Male patient from UNITED STATES , 69 years of age, weighting 134.3 lb, was diagnosed with aspergillosis and was treated with Itraconazole (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, cardiac failure congestive, condition aggravated, respiratory failure. Itraconazole dosage: 200 Mg Bid Po. Patient was hospitalized.

6812490-5 | Histoplasmosis Disseminated, Pseudomonal Sepsis, Pulmonary Embolism
Patient was taking Itraconazole (View Usage). Patient had the following side effects: histoplasmosis disseminated, pseudomonal sepsis, pulmonary embolism (What is pulmonary embolism?) on Jun 25, 2010 from NETHERLANDS Additional patient health information: Male patient , 69 years of age, was diagnosed with histoplasmosis, pyrexia, lymphocytic leukaemia and. Itraconazole dosage: . During the same period patient was treated with POLYGAM S/D (View Polygam S/d Review and Polygam S/d Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), CLAVULANATE POTASSIUM (View Clavulanate Potassium Review and Clavulanate Potassium Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), FLUDARABINE (View Fludarabine Review and Fludarabine Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ).

6782351-9 | Abnormal Faeces, Blood Glucose Decreased, Diarrhoea, Fatigue, Glossodynia, Gouty Arthritis, Hyperhidrosis, Increased Appetite, Influenza Like Illness
Adverse event was reported on Jun 14, 2010 by a Female patient taking Itraconazole (View Usage) (Dosage: 1 Tablet A Day For 14 Days) was diagnosed with ear infection (What is ear infection?) and. Location: DENMARK , weighting 160.9 lb, After Itraconazole was administered, patient had the following side effects: abnormal faeces, blood glucose decreased, diarrhoea, fatigue, glossodynia, gouty arthritis, hyperhidrosis, increased appetite, influenza like illness. During the same period patient was treated with AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ).

6767112-9 | Diarrhoea, Fatigue, Nausea
on Jun 04, 2010 Female patient from UNITED KINGDOM , 47 years of age, was diagnosed with bronchopulmonary aspergillosis allergic, mycobacterial infection and was treated with Itraconazole (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, fatigue, nausea (What is nausea?). Itraconazole dosage: . During the same period patient was treated with RIFAMYCIN (View Rifamycin Review and Rifamycin Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

6767111-7 | Underdose
on Jun 04, 2010 Female patient from UNITED KINGDOM , 41 years of age, was diagnosed with aspergillosis, onychomycosis and was treated with Itraconazole (View Usage). Patient had the following side effects: underdose. Itraconazole dosage: .

6761917-6 | Disease Progression
Patient was taking Itraconazole (View Usage). After Itraconazole was administered, patient had the following side effects: disease progression on Jun 03, 2010 from CHINA Additional patient health information: Male patient , 40 years of age, was diagnosed with aspergillosis and. Itraconazole dosage: . During the same period patient was treated with AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ).

6761915-2 | Disease Progression
Adverse event was reported on Jun 03, 2010 by a Female patient taking Itraconazole (View Usage) (Dosage: ) was diagnosed with aspergillosis and. Location: CHINA , 40 years of age, Patient experienced the following unwanted or unexpected effects: disease progression. During the same period patient was treated with AMPHOTERICIN B (Nebulisation 5-10mg Twice A Day) (View Amphotericin B Review and Amphotericin B Label ).

6760394-9 | Disease Progression
on Jun 03, 2010 Female patient from CHINA , 67 years of age, was diagnosed with aspergillosis and was treated with Itraconazole (View Usage). Patient had the following side effects: disease progression. Itraconazole dosage: . During the same period patient was treated with AMPHOTERICIN B (Nebulisation 5-10mg Twice A Day) (View Amphotericin B Review and Amphotericin B Label ).

6758823-X | Dyspnoea, Haemoperfusion, Haemoptysis, Mechanical Ventilation, Pleural Effusion, Pulmonary Alveolar Haemorrhage
on May 28, 2010 Male patient from JAPAN , 53 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Itraconazole (View Usage). After Itraconazole was administered, patient had the following side effects: dyspnoea, haemoperfusion, haemoptysis, mechanical ventilation, pleural effusion, pulmonary alveolar haemorrhage. Itraconazole dosage: 200 Mg/day. During the same period patient was treated with CARBAZOCHROME SODIUM SULFONATE (View Carbazochrome Sodium Sulfonate Review and Carbazochrome Sodium Sulfonate Label ), TRANEXAMIC ACID (View Tranexamic Acid Review and Tranexamic Acid Label ).

6747413-0 | Haemoptysis, Lymphocyte Stimulation Test Positive, Pulmonary Alveolar Haemorrhage
Patient was taking Itraconazole (View Usage). Patient experienced the following unwanted or unexpected effects: haemoptysis, lymphocyte stimulation test positive, pulmonary alveolar haemorrhage on May 18, 2010 from JAPAN Additional patient health information: Male patient , 53 years of age, was diagnosed with antifungal prophylaxis and. Itraconazole dosage: . During the same period patient was treated with LOXOPROFEN SODIUM (View Loxoprofen Sodium Review and Loxoprofen Sodium Label ), LAFUTIDINE (View Lafutidine Review and Lafutidine Label ), CARBAZOCHROME SODIUM SULFONATE (View Carbazochrome Sodium Sulfonate Review and Carbazochrome Sodium Sulfonate Label ), TRANEXAMIC ACID (View Tranexamic Acid Review and Tranexamic Acid Label ).

6744218-1 | Disease Progression
Adverse event was reported on May 19, 2010 by a Female patient taking Itraconazole (View Usage) (Dosage: ) was diagnosed with pneumonia fungal and. Location: GERMANY , 53 years of age, Patient had the following side effects: disease progression.

6733300-0 | C-reactive Protein Increased, Treatment Failure
on May 19, 2010 Male patient from JAPAN , 20 years of age, was diagnosed with osteomyelitis fungal, prophylaxis and was treated with Itraconazole (View Usage). After Itraconazole was administered, patient had the following side effects: c-reactive protein increased, treatment failure. Itraconazole dosage: . During the same period patient was treated with MICAFUNGIN (View Micafungin Review and Micafungin Label ), INTERFERON GAMMA (View Interferon Gamma Review and Interferon Gamma Label ).

6711046-2 | Hepatotoxicity
on Apr 28, 2010 Male patient from FRANCE , 19 years of age, weighting 174.2 lb, was diagnosed with antifungal prophylaxis and was treated with Itraconazole (View Usage). Patient experienced the following unwanted or unexpected effects: hepatotoxicity. Itraconazole dosage: .

6696544-2 | Asthenia, Contusion, Cushingoid, Hirsutism, Muscle Atrophy, Overweight, Tremor
Patient was taking Itraconazole (View Usage). Patient had the following side effects: asthenia, contusion, cushingoid, hirsutism, muscle atrophy, overweight, tremor on Apr 15, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 67 years of age, was diagnosed with bronchopulmonary aspergillosis allergic and. Itraconazole dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), ALENDRONIC ACID (View Alendronic Acid Review and Alendronic Acid Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), HUMULIN INSULIN (View Humulin Insulin Review and Humulin Insulin Label ), SERETIDE (View Seretide Review and Seretide Label ), SALBUTAMOL (View Salbutamol Review and Salbutamol Label ).